MeSH Browser

MeSH Heading: Mitoxantrone
Tree Number(s): D02.455.426.559.847.117.380.625.500; D02.806.100.500; D04.615.125.380.625.500
Unique ID: D008942
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D008942
Scope Note: An anthracenedione-derived antineoplastic agent.
Entry Term(s): CL-232325; DHAQ; Mitoxantrone Acetate; Mitoxantrone Hydrochloride; Mitozantrone; Mitroxone; NSC-279836; NSC-287836; NSC-299195; NSC-301739; NSC-301739D; Novantron; Novantrone; Onkotrone; Pralifan; Ralenova
Pharm Action: Analgesics
Antineoplastic Agents
Topoisomerase II Inhibitors
Registry Numbers: BZ114NVM5P; 0; U6USW86RD0; 70711-41-0
Related Numbers: 65271-80-9; 70476-82-3; 70711-41-0; U6USW86RD0
CAS Type 1 Name: 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-
NLM Classification #: QV 269
Previous Indexing: Anthraquinones (1966-1986)
Public MeSH Note: 87
History Note: 87
Date Established: 1987/01/01
Date of Entry: 1986/06/03
Revision Date: 2023/06/07

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Mitoxantrone MeSH Descriptor Data 2025